---
layout: post
title: IDSWG Oncology Newsletter
subtitle: January 1, 2024
author: Haijun Ma, Fengyu Zhao, Philip He, Laura Fernandes and Haoda Fu
tags: [newsletter]
comments: true
thumbnail-img: /assets/img/blog/2024-01-01-newsletter/fig1.png
---

<figurecenter>
<img class="center" src="/assets/img/blog/2024-01-01-newsletter/fig1.png" alt="Figure 1">
</figurecenter>


We are pleased to present the first issue of our Oncology Working Group's Newsletter covering compilation of insights, trends, and analyses that shed light on the evolving landscape of statistics in oncology. In this issue, the following panels are included: (1) Notes from the chairs; (2) KOL Message from Dr. Haoda Fu; (3) WG Updates; (4) FDA NDA/BLA recent approvals in oncology in 2023 with links to the agencyâ€™s review documents; and (5) Biostat Byte, a panel designated to promote understanding of statistical terms in layman English for drug developers. 
 
The link to the newsletter is [https://zenodo.org/records/10451546](https://zenodo.org/records/10451546)

Happy reading!